DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCorporate Action

Sun Pharmaceutical Industries Limited — Change in Directors/KMP/SMP/Auditor/RTA

NSE 1 hr ago·12 Oct 2026, 3:04 pm

SUN Pharmaceutical IND L

Sun Pharmaceutical Industries Limited has informed the stock exchanges about a change in its leadership structure. The company has appointed a new Company Secretary and Compliance Officer, replacing the previous incumbent. Additionally, the firm has updated the details of its Registered Transfer Agent (RTA). These are routine administrative changes that are standard for a large, listed entity.

For investors, this news is largely procedural and typically does not carry immediate financial implications. The roles of Company Secretaries and RTAs are crucial for ensuring regulatory compliance and smooth share transfer processes, but the change in personnel does not signal any shift in the company's strategic direction or operational performance.

Investors should monitor the official exchange filings for the complete list of new appointments. While this update is neutral, it is prudent to keep an eye on any subsequent disclosures regarding the background of the new appointees to ensure business continuity remains unaffected.